ClinConnect ClinConnect Logo
Search / Trial NCT06785376

P3 Trial: Estimating the Impact of a Multilevel, Multicomponent Intervention to Increase Uptake of HIV Testing and Biomedical HIV Prevention Among African-American/Black Gay, Bisexual, and Same-gender Loving Men

Launched by COLUMBIA UNIVERSITY · Jan 16, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Hiv Testing Pr Ep Uptake Hiv Prevention Men Who Have Sex With Men

ClinConnect Summary

This clinical trial is studying a new approach to increase HIV testing and the use of preventive treatments among Black gay, bisexual, and same-gender loving men in New York City. The goal is to address barriers that prevent people from getting tested for HIV and using preventive medications called PrEP (Pre-exposure Prophylaxis) and PEP (Post-exposure Prophylaxis). The study will involve 480 participants who are eligible for PrEP and will be randomly assigned to one of four different groups, each receiving a combination of interventions over 18 months.

To be eligible, participants must be assigned male at birth, aged 18 to 65, and self-identify as Black or a related ethnicity. They should also live in the NYC area, not be HIV-positive, and have engaged in sex with another man in the past six months. Participants will receive support and information to help them navigate HIV testing and preventive services. This trial is currently recruiting, and it's an important step towards improving health outcomes in the community.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • 1. assigned biological male sex at birth;
  • 2. 18-65 years of age;
  • 3. self-identify as: Black, African-American, Afro-Caribbean, Black African, Afro-Latino or multiethnic Black;
  • 4. reside in the NYC metro area; (5) not HIV-positive (tested before randomization);
  • 6) report insertive or receptive anal intercourse with another man in the past six months; 7) not currently on PEP or PrEP; 8) communicate in English or Spanish; 9) provide informed consent for the study.
  • Exclusion Criteria:
  • Sexual identity is not an exclusion criterion
  • potential participants who self-identify as Latino must also identify as Black (as per above) to be included

About Columbia University

Columbia University, a prestigious Ivy League institution located in New York City, is a leading sponsor of clinical trials dedicated to advancing medical research and improving patient care. With a robust network of research facilities and a commitment to innovation, Columbia University collaborates with a diverse range of healthcare professionals and researchers to explore groundbreaking therapies and treatment methodologies. The university's clinical trials encompass various fields, including oncology, neurology, and public health, aiming to translate scientific discoveries into effective clinical applications. Columbia University is dedicated to maintaining the highest ethical standards and regulatory compliance, ensuring the safety and well-being of trial participants while contributing to the global body of medical knowledge.

Locations

New York, New York, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported